Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-205799
Filing Date
2025-09-17
Accepted
2025-09-17 12:03:12
Documents
7
Period of Report
2025-09-17

Document Format Files

Seq Description Document Type Size
1 6-K d26807d6k.htm 6-K 9599
2 EX-99.1 d26807dex991.htm EX-99.1 20792
3 EX-99.2 d26807dex992.htm EX-99.2 16069
4 EX-99.3 d26807dex993.htm EX-99.3 24448
5 GRAPHIC g26807g0916155329783.jpg GRAPHIC 2471
6 GRAPHIC g26807g0917162732469.jpg GRAPHIC 2601
7 GRAPHIC g26807g77a40.jpg GRAPHIC 4876
  Complete submission text file 0001193125-25-205799.txt   86138
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251319226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)